Literature DB >> 16435361

Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.

Weiping Ren1, Bin Wu, Xin Peng, Lois Mayton, Dongzi Yu, Juanjie Ren, Ben D Chen, Paul H Wooley.   

Abstract

Up to 20% of patients with total joint arthroplasty will develop radiographic evidence of aseptic loosening (AL), which most likely results from an inflammatory response to billions of wear debris shed from the implant. Our previous work has demonstrated that erythromycin (EM), a macrolide antibiotic, inhibits wear debris-induced inflammatory osteoclastogenesis through the reduction of cytokine production and osteoclast differentiation, both of which involve the NF-kappaB pathway. The aim of the current study was to determine whether EM inhibits wear debris-induced inflammatory osteolysis in a murine osteolysis model. Ultrahigh molecular-weight polyethylene (UHMWPE) debris was introduced into established air pouches on BALB/c mice, followed by implantation of calvaria bone from syngeneic littermates. EM (2 mg/kg/day) was given to mice intraperitoneally 2 days before UHMWPE introduction and maintained until the sacrifice of the mice. Mice with and without EM treatment, as well as control mice injected with saline alone were included in this study. Pouch tissues were collected 14 days after UHMWPE inoculation for molecular and histology analysis. Our findings indicate that: (1) EM reduced UHMWPE-induced tissue inflammation, including the diminished pouch membrane thickness, reduced inflammatory cellular infiltration, and lowered IL-1beta and TNF-alpha expression (mRNA and protein); (2) EM inhibited UHMWPE-induced osteoclastogenesis, with reduced gene activation of RANK, RANKL, and CPK, and diminished RANKL expression in UHMWPE stimulated pouches, and (3) EM markedly reduced the number of TRAP(+) cells in pouch tissues, and protected against bone collagen depletion. In conclusion, this study provides the evidence that EM inhibits the UHMWPE particles-induced inflammatory osteolysis in a murine model, and represents a promising therapeutic candidate for the prevention and treatment of AL. (c) 2005 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16435361     DOI: 10.1002/jor.20004

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  14 in total

1.  Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis.

Authors:  Shan Jin; Ju Young Park; Jung Min Hong; Tae Ho Kim; Hong In Shin; Eui Kyun Park; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  'Old drugs for new applications': can orthopedic research benefit from this strategy?

Authors:  Xiaohua Pan; Wenxiang Cheng; Jiali Wang; Ling Qin; Yuxiao Lai; Jian Tang; Peng Shang; Peigen Ren; Peng Zhang
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-08       Impact factor: 5.346

Review 3.  Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?

Authors:  Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

4.  Emerging ideas: can erythromycin reduce the risk of aseptic loosening?

Authors:  Weiping Ren; David C Markel
Journal:  Clin Orthop Relat Res       Date:  2011-05-17       Impact factor: 4.176

5.  Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis.

Authors:  Weiping Ren; Renwen Zhang; Monica Hawkins; Tong Shi; David C Markel
Journal:  Inflamm Res       Date:  2010-07-06       Impact factor: 4.575

6.  Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysis.

Authors:  Allison J Rao; Stefan Zwingenberger; Roberto Valladares; Chenguang Li; Robert Lane Smith; Stuart B Goodman; Christophe Nich
Journal:  Int Orthop       Date:  2013-04-21       Impact factor: 3.075

7.  Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.

Authors:  David C Markel; Renwen Zhang; Tong Shi; Monica Hawkins; Weiping Ren
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

8.  The Chondroprotective Role of Erythromycin in a Murine Joint Destruction Model.

Authors:  Tomoya Uchimura; Andrea T Foote; David C Markel; Weiping Ren; Li Zeng
Journal:  Cartilage       Date:  2016-02-17       Impact factor: 4.634

Review 9.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.

Authors:  S B Goodman; E Gibon; J Pajarinen; T-H Lin; M Keeney; P-G Ren; C Nich; Z Yao; K Egashira; F Yang; Y T Konttinen
Journal:  J R Soc Interface       Date:  2014-01-29       Impact factor: 4.118

10.  Locally delivered minocycline microspheres do not impair osseointegration of titanium implants in a rat femur model.

Authors:  Joshua A Shapiro; Samuel AbuMoussa; Christopher P Lindsay; Gabriel B Mason; Laurence E Dahners; Paul S Weinhold
Journal:  J Orthop       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.